Related Business Topics
Latest Headlines
Forbes.com - Nov. 18, 2009, 5:46 AM
- GeneNews licenses exclusive marketing rights for colorectal cancer blood test to Enzo for key states of New York and New Jersey - TORONTO, Nov. 18 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), an emerging molecular diagnostics and personalized ...
Reuters - Nov. 18, 2009, 4:37 AM
Agreement Covers Enzo Clinical Labs' Service Area NEW YORK--(Business Wire)-- Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has entered into an agreement with GeneNews (TSX: GEN), of Toronto, Canada, for exclusive rights to market GeneNews' ...
Reuters - Nov. 18, 2009, 4:35 AM
Georgia Bank of Georgia Announces the Venue and Timetable of the Investor Day to Be Held in New York on 23 November Reuters adsrc 'reuters.com.dart/bizfinance/stocks/pressrelease/article;' ( typeof(AD_TRACKER) 'undefined' AD_TRACKER.globalAdSrcType null ...
Reuters - Nov. 18, 2009, 4:31 AM
partners with Enzo Clinical to market ColonSentry(TM) in the Reuters adsrc 'reuters.com.dart/bizfinance/stocks/pressrelease/article;' ( typeof(AD_TRACKER) 'undefined' AD_TRACKER.globalAdSrcType null ) if Reuters top ten news stories delivered to your ...
CNBC - Nov. 13, 2009, 7:17 AM
Reuters - Oct. 15, 2009, 9:53 PM
THOMSON REUTERS, Corporate Conference Call/Webcast for US Companies for Thursday, Oct 15, 2009. S&P 500 Earnings - Weekly [SP500/WK] S&P 500 Earnings - Day Ahead [ESTEARN/SP] Non S&P 500 - Weekly [NSP500/WK] Non S&P 500 - Day Ahead [ESTEARN/] ...
Reuters - Oct. 15, 2009, 9:53 PM
THOMSON REUTERS, Oct 14, Diary of Non S&P 500 Corporate earnings for U.S.companies to Oct 28, 2009. S&P 500 Earnings - Monthly [RESF/US] S&P 500 Earnings - Day Ahead [ESTEARN/SP] S&P 500 Earnings - Weekly [SP500/WK] Non S&P 500 - Day Ahead [ESTEARN/] ...
Forbes.com - Oct. 15, 2009, 6:23 AM
BusinessWire - Enzo Biochem, Inc. (NYSE:ENZ) today said that its Life Sciences subsidiary will release a new catalog dealing with 'Epigenetics & Chromatin Modification' at the Society for Neuroscience's, Neuroscience 2009 conference, beginning October ...
CNBC - Oct. 14, 2009, 4:27 PM
NEW YORK - Biotechnology company Enzo Biochem Inc. said Wednesday its fiscal fourth-quarter loss widened on a rise in general and administrative costs. For the three months ended July 31, the company lost $5.3 million, or 14 cents per share, compared ...
Forbes.com - Oct. 14, 2009, 2:19 PM
BusinessWire - Enzo Biochem, Inc. (NYSE:ENZ) today reported a 16% increase in total operating revenue, to $24.5 million, and a 19% increase in gross profit, to $10.6 million, for the fourth fiscal quarter ended July 31, over the comparable quarter last ...
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
E
Enzo Diagnostics, Inc.
Manufacturer of highly specialized diagnostic biotechnology products. The products use nonradioactive methods for tumor origin indentification and they visualize molecules by using Biotin-Avadin technology to tag enzymes and probe for viruses a...
www.enzo.com
Manufacturer of highly specialized diagnostic biotechnology products. The products use nonradioactive methods for tumor origin indentification and they visualize molecules by using Biotin-Avadin technology to tag enzymes and probe for viruses a...
www.enzo.com
